Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Idexx Laboratories (IDXX)
:IDXX
Earnings Data
Report Date
Apr 30, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
2.86Last Year’s EPS
2.81Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 03, 2025
|% Change Since: 7.30%
|Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance and growth across several segments, bolstered by successful product launches and international expansion. However, challenges such as a decline in US clinical visits and litigation expenses were noted. Overall, the positive aspects of IDEXX's performance and strategic advancements in innovation outweighed the challenges.Company Guidance
During the IDEXX Laboratories Fourth Quarter 2024 Earnings Conference Call, the company provided guidance for 2025, forecasting revenue growth of 4% to 7% on a reported basis and 6% to 9% organically. IDEXX anticipates 5% to 8% organic growth in CAG Diagnostics recurring revenues, with a 2% negative impact on full-year revenue from foreign exchange. Key drivers include global net price realization of 4% to 4.5% and volume gains of about 2%. Operating margins are expected to improve by 30 to 80 basis points year-over-year, with EPS projected to rise 8% to 12% on a comparable basis, reflecting the lapping of a 2024 litigation expense. IDEXX plans for $42 million in net interest expense and a net income to free cash flow conversion of 85% to 90%, supported by $160 million in capital spending. The company is also targeting $1.5 billion in share repurchases, reflecting confidence in its growth potential.Solid Fourth Quarter Financial Performance
IDEXX's fourth quarter revenue increased 6% organically, with operating profits increasing 7% as reported and 8% on a comparable basis. EPS for Q4 was $2.62, up 10% on a comparable basis.
Full Year 2024 Achievements
Full year organic growth in CAG Diagnostics recurring revenues was 7%, with 9% growth in the global premium instrument installed base, and 11% organic growth in the Water business. Full year EPS was $10.67 per share, up 12% on a comparable basis.
Launch of IDEXX inVue Dx and IDEXX Cancer Dx
IDEXX launched the inVue Dx, a slide-free Point-of-Care cellular analyzer, and Cancer Dx with canine lymphoma, a new oncology screening panel.
Strong International Growth
International CAG Diagnostic recurring revenue growth was 12% in Q4, with double-digit year-on-year growth in the international premium instrument installed base.
High Customer Retention and New Business Gains
IDEXX maintained high customer retention levels and achieved solid new business gains, contributing to strong performance.
---
IDXX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
IDXX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 03, 2025 | $422.05 | $469.04 | +11.13% |
| Oct 31, 2024 | $451.08 | $406.92 | -9.79% |
| Aug 06, 2024 | $455.08 | $469.37 | +3.14% |
| May 01, 2024 | $492.76 | $468.04 | -5.02% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Idexx Laboratories (IDXX) report earnings?
Idexx Laboratories (IDXX) is schdueled to report earning on Apr 30, 2025, TBA Not Confirmed.
What is Idexx Laboratories (IDXX) earnings time?
Idexx Laboratories (IDXX) earnings time is at Apr 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is IDXX EPS forecast?
IDXX EPS forecast for the fiscal quarter 2025 (Q1) is 2.86.
---